Research of Exenatide for Overweight/Obese PCOS Patients With IGR
Phase 4
Completed
- Conditions
- Overweight and ObesityDisorder of Glucose RegulationPolycystic Ovary Syndrome
- Interventions
- First Posted Date
- 2017-11-24
- Last Posted Date
- 2019-09-11
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 183
- Registration Number
- NCT03352869
- Locations
- 🇨🇳
Renji Hospital Department of Endocrinology and Metabolism, Shanghai, China
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Gastroscopy Sedated by Propofol
Not Applicable
Completed
- Conditions
- HypoxiaEsophagus CancerAdverse EventGastric Cancer
- Interventions
- Device: High-flow nasal cannula oxygenation
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2018-09-05
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 2034
- Registration Number
- NCT03332433
- Locations
- 🇨🇳
Shanghai Tongji Hospital, Shanghai, Shanghai, China
🇨🇳Renji hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, Shanghai, China
🇨🇳Shanghai Pudong New Area People's Hospital, Shanghai, Shanghai, China
Assessment of Somatic Symptom Burden
Recruiting
- Conditions
- Somatization Disorder
- Interventions
- Diagnostic Test: The general populationDiagnostic Test: Patients with suspected CAD
- First Posted Date
- 2017-10-25
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT03321409
- Locations
- 🇨🇳
Renji Hospital, Shanghai, China
Accuracy, Feasibility and Acceptance of CGM Lupus
Not Applicable
- Conditions
- Critical IllnessSystemic Lupus ErythematosusDiabetic Blood Glucose Monitoring
- Interventions
- Device: Flash glucose monitoring system
- First Posted Date
- 2017-09-29
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT03296995
- Locations
- 🇨🇳
Shuang Ye, MD, Shanghai, Shanghai, China
Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP
Phase 4
Completed
- Conditions
- ST Segment Elevation Myocardial InfarctionCoronary Slow Flow Phenomenon
- Interventions
- First Posted Date
- 2017-09-28
- Last Posted Date
- 2020-03-12
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 57
- Registration Number
- NCT03296670
- Locations
- 🇨🇳
Ren Ji Hospital Afflited to School of Medicine, Shanghai Jiao Tong University, ShangHai, China
Differentiation HHD From HCM (EARLY-MYO-HHD)
Completed
- Conditions
- Hypertrophic CardiomyopathyHypertensive Heart Disease
- Interventions
- Diagnostic Test: evaluated by the predetermined differentiating formula
- First Posted Date
- 2017-09-05
- Last Posted Date
- 2022-11-17
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 465
- Registration Number
- NCT03271385
- Locations
- 🇨🇳
Renji Hospital, Shanghai, China
Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI
Phase 4
- Conditions
- ST Segment Elevation Myocardial Infarction
- Interventions
- First Posted Date
- 2017-08-17
- Last Posted Date
- 2017-08-17
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 600
- Registration Number
- NCT03252665
- Locations
- 🇨🇳
Ren Ji Hospital Afflited to School of Medicine, Shanghai Jiao Tong University, ShangHai, China
Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic Stroke
Phase 2
- Conditions
- Ischemic Stroke
- Interventions
- First Posted Date
- 2017-07-17
- Last Posted Date
- 2017-07-17
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT03219645
Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women
Phase 3
Recruiting
- Conditions
- Tubular Breast CancerMucinous Breast CancerInvasive Duct Carcinoma of Breast
- Interventions
- Drug: Paclitaxel, CisplatinDrug: EC to docetaxel or paclitaxel
- First Posted Date
- 2017-06-28
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 762
- Registration Number
- NCT03201861
- Locations
- 🇨🇳
Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, Shanghai, China
Basiliximab Treating Interstitial Pneumonia of CADM
Phase 2
- Conditions
- Lung; Disease, Interstitial, With FibrosisDermatomyositis
- Interventions
- First Posted Date
- 2017-06-20
- Last Posted Date
- 2017-06-20
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT03192657
- Locations
- 🇨🇳
RenJi Hospital, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath